Predictive Value of the DD4 Questionnaire on Depressive Relapse After Hospitalization
Launched by GCS RAMSAY SANTÉ POUR L'ENSEIGNEMENT ET LA RECHERCHE · Dec 22, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how well a questionnaire called the DD4 can predict whether someone will experience a relapse of depression after being hospitalized. The study involves patients who have recently been treated for a depressive episode and will follow up with them three months after they leave the hospital to see how they are doing.
To be eligible for this study, participants need to be at least 18 years old and have been hospitalized for depression, but are now considered to be in remission, meaning their symptoms have improved. They should have a specific score on a depression assessment tool that indicates they are doing better. However, individuals who were hospitalized for less than 15 days, have bipolar disorder, or other specific mental health conditions will not be included. If you decide to participate, you'll be asked to complete a questionnaire about your mood and experiences after your hospital stay. This research aims to help improve future treatments for depression.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient 18 years of age or older, having been informed of the research
- • Patient hospitalized at the Auzon Clinic for a characterized depressive episodé (isolated episode or recurrent depressive disorder)
- • Discharged from hospitalization
- • Considered in remission (total or partial) and with a MADRS score \< 20
- Exclusion Criteria:
- • Patient hospitalized for \< 15 days
- • Patient with bipolar depression
- • Patient with a psychotic disorder
- • Patient using narcotics with a "moderate to severe" severity
- • Patient previously included in this study
- • Patient under court protection, guardianship or curatorship
- • Patient unablé to respond correctly to a depression self-assessment questionnaire
About Gcs Ramsay Santé Pour L'enseignement Et La Recherche
GCS Ramsay Santé pour l'Enseignement et la Recherche is a leading clinical trial sponsor dedicated to advancing healthcare through innovative research and education. As a collaborative group, it unites academic institutions and healthcare professionals to facilitate high-quality clinical trials that enhance patient care and contribute to medical knowledge. With a focus on rigorous scientific standards and ethical practices, GCS Ramsay Santé plays a crucial role in the development of new therapies and treatment protocols, ensuring that cutting-edge research translates into tangible benefits for patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
La Roche Blanche, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials